285 related articles for article (PubMed ID: 29186452)
1. Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women?
Florijn BW; Bijkerk R; van der Veer EP; van Zonneveld AJ
Cardiovasc Res; 2018 Feb; 114(2):210-225. PubMed ID: 29186452
[TBL] [Abstract][Full Text] [Related]
2. Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.
Kriegel AJ; Gartz M; Afzal MZ; de Lange WJ; Ralphe JC; Strande JL
J Cardiovasc Transl Res; 2017 Jun; 10(3):295-304. PubMed ID: 28032312
[TBL] [Abstract][Full Text] [Related]
3. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
4. Why are women more likely than men to develop heart failure with preserved ejection fraction?
Scantlebury DC; Borlaug BA
Curr Opin Cardiol; 2011 Nov; 26(6):562-8. PubMed ID: 21993357
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
6. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
7. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.
Dong S; Ma W; Hao B; Hu F; Yan L; Yan X; Wang Y; Chen Z; Wang Z
Int J Clin Exp Pathol; 2014; 7(2):565-74. PubMed ID: 24551276
[TBL] [Abstract][Full Text] [Related]
8. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle.
Rech M; Barandiarán Aizpurua A; van Empel V; van Bilsen M; Schroen B
Cardiovasc Res; 2018 May; 114(6):782-793. PubMed ID: 29462282
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.
Li X; Sun M; Wang Z; Sun S; Wang Y
Eur J Clin Invest; 2024 Mar; 54(3):e14130. PubMed ID: 38071416
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific microRNAs in women with diabetes and left ventricular diastolic dysfunction or HFpEF associate with microvascular injury.
Florijn BW; Valstar GB; Duijs JMGJ; Menken R; Cramer MJ; Teske AJ; Ghossein-Doha C; Rutten FH; Spaanderman MEA; den Ruijter HM; Bijkerk R; van Zonneveld AJ
Sci Rep; 2020 Aug; 10(1):13945. PubMed ID: 32811874
[TBL] [Abstract][Full Text] [Related]
12. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
Gori M; Lam CS; Gupta DK; Santos AB; Cheng S; Shah AM; Claggett B; Zile MR; Kraigher-Krainer E; Pieske B; Voors AA; Packer M; Bransford T; Lefkowitz M; McMurray JJ; Solomon SD;
Eur J Heart Fail; 2014 May; 16(5):535-42. PubMed ID: 24574260
[TBL] [Abstract][Full Text] [Related]
14. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
Beale AL; Meyer P; Marwick TH; Lam CSP; Kaye DM
Circulation; 2018 Jul; 138(2):198-205. PubMed ID: 29986961
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction.
Samson R; Le Jemtel TH
J Am Heart Assoc; 2021 Jun; 10(12):e021120. PubMed ID: 34056916
[TBL] [Abstract][Full Text] [Related]
17. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
[TBL] [Abstract][Full Text] [Related]
18. Obesity and heart failure with preserved ejection fraction: A growing problem.
Prenner SB; Mather PJ
Trends Cardiovasc Med; 2018 Jul; 28(5):322-327. PubMed ID: 29305040
[TBL] [Abstract][Full Text] [Related]
19. The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.
Lo CI; Lai YH; Chang SN; Kuo JY; Hsieh YC; Bulwer BE; Hung CL; Yeh HI
Clin Exp Hypertens; 2017; 39(5):473-480. PubMed ID: 28569600
[TBL] [Abstract][Full Text] [Related]
20. [Heart failure with preserved ejection fraction (HFpEF)].
Maeder MT; Buser M; Brenner R; Rickli H
Ther Umsch; 2018 Sep; 75(3):161-169. PubMed ID: 30145974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
